Lv7
5000 积分 2023-04-18 加入
Peri-transplant ruxolitinib in myelofibrosis patients undergoing αβTCR and CD19-depleted stem cell transplantation
24天前
已完结
[Practice guideline for acute infectious diarrhea in Chinese children]
1个月前
已完结
Hematopoietic cell transplantation (HCT)-specific comorbidity index: a new tool for risk assessment before allogeneic HCT
2个月前
已完结
Targeted treatment of anemia in myelofibrosis and the impact of JAK inhibitors
2个月前
已完结
Primary Myelofibrosis (PMF)-The German ONKOPEDIA Guideline 2025
4个月前
已完结
Thrombocytosis Phenotype in Prefibrotic Primary Myelofibrosis: Risk Stratification and Prognostic Significance
4个月前
已完结
MoReLife - real-life data support the potential of momelotinib as a safe and effective treatment option for cytopenic myelofibrosis patients
4个月前
已完结
Doubling down: the new deal in the clinical management of double-refractory chronic lymphocytic leukemia
5个月前
已完结
Cutaneous Toxicities of Small Molecules in Targeted Cancer Therapy Part I – Mechanisms of Toxicity
5个月前
已完结
Advances and resistance adaptation in BTK-targeted therapy for B-cell malignancies
5个月前
已完结